Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
AmgenAMGN |
77 0% |
 |
Gilead SciencesGILD |
59 1.7% |
 |
Catalyst PharmaceuticalsCPRX |
100 0% |
 |
Inovio PharmaceuticalsINO |
23 0% |
 |
Anavex Life SciencesAVXL |
0 0% |
Month over Month
Employee view on business outlook (0 - 100)
| Nov 2024 | 93 | |
| Oct 2024 | 93 | |
| Sep 2024 | 93 | |
| Aug 2024 | 93 |
How do employees feel about the future at BridgeBio Pharma?
The Business Outlook at BridgeBio Pharma is very positive according to its employees. The average outlook rating of 93 (out of 100) is very high according to data from the top review sites in the US.
Analyzing Business Outlook, how is BridgeBio Pharma performing compared to its industry peers?
BridgeBio Pharma overperforms a majority of its industry peers when it comes to Business Outlook, ranking in the 93rd percentile.
How has the business outlook at BridgeBio Pharma changed over the last couple of months
There has been no meaningful change in the business outlook amongst employees at BridgeBio Pharma.
Why is it important to track the business outlook at BridgeBio Pharma?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at BridgeBio Pharma.
